- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Human papillomavirus virus
- Meeting Date: December 2022
- Public Summary Document (PSD) December 2022 PBAC Meeting - (PDF 507KB)
- Public Summary Document (PSD) December 2022 PBAC Meeting - (Word 283KB)
Human papillomavirus 9-valent vaccine – December 2022
Human papillomavirus 9-valent vaccine: Injection 0.5 mL, pre-filled syringe; Gardasil®9 – December 2022
Last updated
7 July 2025